Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.

      FDA Approvals
      Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA has authorized for emergency use a booster...

      Cellbox Solutions Introduces CBS Naturally-3D Kits in Cooperation with UPM Biomedicals

      Drug Development
      Cellbox Solutions GmbH is expanding its product portfolio: The Cellbox Solutions Packaging, which enables the best-in-class transport of living cell and tissue cultures, is...

      Overcoming challenges in effervescent dosage manufacturing

      Drug Development
      To improve the taste and stability of effervescent tablets and powders, BENEO presents galenIQ™ 721. This filler-binder enables pharmaceutical and nutraceutical manufacturers to target...

      Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment

      Drug Development
      Aichi Cancer Center (1) and Fujitsu Limited  announced the development of an AI solution able to select effective medical treatment from a wide range...

      Cellumed and ARTES Sign Development and License Agreement

      Drug Development
      Cellumed Co. Ltd., listed stock market company and Germany based ARTES Biotechnology GmbH announce the execution of a Development and License Agreement aiming at...

      BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery

      Drug Development
      BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the BD SCF™ PremiumCoat®† Plunger Stopper in partnership with...

      Merck and Ridgeback Announce Submission of EUA Application to the U.S. FDA for Molnupiravir for the Treatment of COVID-19 in At Risk Adults

      FDA Approvals
      Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that Merck has submitted an Emergency Use Authorization (EUA) application...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.